Literature DB >> 27305829

Exosomes: Tunable Nano Vehicles for Macromolecular Delivery of Transferrin and Lactoferrin to Specific Intracellular Compartment.

Himanshu Malhotra, Navdeep Sheokand, Santosh Kumar, Anoop S Chauhan, Manoj Kumar, Priyanka Jakhar, Vishant M Boradia, Chaaya I Raje, Manoj Raje.   

Abstract

Due to their abundant ubiquitous presence, rapid uptake and increased requirement in neoplastic tissue, the delivery of the iron carrier macromolecules transferrin (Tf) and lactoferrin (Lf) into mammalian cells is the subject of intense interest for delivery of drugs and other target molecules into cells. Utilizing exosomes obtained from cells of diverse origin we confirmed the presence of the multifunctional protein glyceraldehyde-3-phosphate dehydrogenase (GAPDH) which has recently been characterized as a Tf and Lf receptor. Using a combination of biochemical, biophysical and imaging based methodologies, we demonstrate that GAPDH present in exosomes captures Tf and Lf and subsequently effectively delivers these proteins into mammalian cells. Exosome vesicles prepared had a size of 51.2 ± 23.7 nm. They were found to be stable in suspension with a zeta potential (ζ-potential) of -28.16 ± 1.15 mV. Loading of Tf/Lf did not significantly affect ζ-potential of the exosomes. The carrier protein loaded exosomes were able to enhance the delivery of Tf/Lf by 2 to 3 fold in a diverse panel of cell types. Ninety percent of the internalized cargo via this route was found to be specifically delivered into late endosome and lysosomes. We also found exosomes to be tunable nano vehicles for cargo delivery by varying the amount of GAPDH associated with exosome. The current study opens a new avenue of research for efficient delivery of these vital iron carriers into cells employing exosomes as a nano delivery vehicle.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27305829     DOI: 10.1166/jbn.2016.2229

Source DB:  PubMed          Journal:  J Biomed Nanotechnol        ISSN: 1550-7033            Impact factor:   4.099


  27 in total

1.  Measurement and standardization challenges for extracellular vesicle therapeutic delivery vectors.

Authors:  Bryant C Nelson; Samantha Maragh; Ionita C Ghiran; Jennifer C Jones; Paul C DeRose; Elzafir Elsheikh; Wyatt N Vreeland; Lili Wang
Journal:  Nanomedicine (Lond)       Date:  2020-09-04       Impact factor: 5.307

2.  Ferritin is secreted via 2 distinct nonclassical vesicular pathways.

Authors:  Marianna Truman-Rosentsvit; Dina Berenbaum; Lior Spektor; Lyora A Cohen; Shirly Belizowsky-Moshe; Lena Lifshitz; Jing Ma; Wei Li; Ellina Kesselman; Inbal Abutbul-Ionita; Dganit Danino; Lucia Gutierrez; Huihui Li; Kuanyu Li; Huifang Lou; Maria Regoni; Maura Poli; Fabian Glaser; Tracey A Rouault; Esther G Meyron-Holtz
Journal:  Blood       Date:  2017-10-26       Impact factor: 22.113

3.  Host glyceraldehyde-3-phosphate dehydrogenase-mediated iron acquisition is hijacked by intraphagosomal Mycobacterium tuberculosis.

Authors:  Anil Patidar; Himanshu Malhotra; Surbhi Chaudhary; Manoj Kumar; Rahul Dilawari; Gaurav Kumar Chaubey; Asmita Dhiman; Radheshyam Modanwal; Sharmila Talukdar; Chaaya Iyengar Raje; Manoj Raje
Journal:  Cell Mol Life Sci       Date:  2022-01-09       Impact factor: 9.261

4.  Development and MPI tracking of novel hypoxia-targeted theranostic exosomes.

Authors:  Kyung Oh Jung; Hunho Jo; Jung Ho Yu; Sanjiv Sam Gambhir; Guillem Pratx
Journal:  Biomaterials       Date:  2018-05-29       Impact factor: 12.479

Review 5.  Is Extracellular Vesicle-Based Therapy the Next Answer for Cartilage Regeneration?

Authors:  Émilie Velot; Henning Madry; Jagadeesh K Venkatesan; Arnaud Bianchi; Magali Cucchiarini
Journal:  Front Bioeng Biotechnol       Date:  2021-04-23

Review 6.  Functional Nucleic Acid Nanomaterials: Development, Properties, and Applications.

Authors:  Wentao Xu; Wanchong He; Zaihui Du; Liye Zhu; Kunlun Huang; Yi Lu; Yunbo Luo
Journal:  Angew Chem Int Ed Engl       Date:  2020-08-25       Impact factor: 16.823

Review 7.  Exosome-Based Cancer Therapy: Implication for Targeting Cancer Stem Cells.

Authors:  Jinheng Wang; Yongjiang Zheng; Meng Zhao
Journal:  Front Pharmacol       Date:  2017-01-12       Impact factor: 5.810

8.  Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells.

Authors:  Gaofeng Liang; Shu Kan; Yanliang Zhu; Shuying Feng; Wenpo Feng; Shegan Gao
Journal:  Int J Nanomedicine       Date:  2018-01-30

9.  Proteomic analysis of extracellular vesicles from a Plasmodium falciparum Kenyan clinical isolate defines a core parasite secretome.

Authors:  Abdirahman Abdi; Lu Yu; David Goulding; Martin K Rono; Philip Bejon; Jyoti Choudhary; Julian Rayner
Journal:  Wellcome Open Res       Date:  2017-11-22

Review 10.  An Update on in Vivo Imaging of Extracellular Vesicles as Drug Delivery Vehicles.

Authors:  Prakash Gangadaran; Chae Moon Hong; Byeong-Cheol Ahn
Journal:  Front Pharmacol       Date:  2018-02-28       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.